NO20004491D0 - Blanding - Google Patents
BlandingInfo
- Publication number
- NO20004491D0 NO20004491D0 NO20004491A NO20004491A NO20004491D0 NO 20004491 D0 NO20004491 D0 NO 20004491D0 NO 20004491 A NO20004491 A NO 20004491A NO 20004491 A NO20004491 A NO 20004491A NO 20004491 D0 NO20004491 D0 NO 20004491D0
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Confectionery (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7748098P | 1998-03-11 | 1998-03-11 | |
| US7752798P | 1998-03-11 | 1998-03-11 | |
| GBGB9805192.3A GB9805192D0 (en) | 1998-03-11 | 1998-03-11 | Composition |
| PCT/EP1999/001557 WO1999045924A1 (en) | 1998-03-11 | 1999-03-05 | Composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004491D0 true NO20004491D0 (no) | 2000-09-08 |
| NO20004491L NO20004491L (no) | 2000-09-08 |
Family
ID=27269240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004491A NO20004491L (no) | 1998-03-11 | 2000-09-08 | Blanding |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6451343B1 (no) |
| EP (1) | EP1061918A1 (no) |
| JP (1) | JP2002506031A (no) |
| KR (1) | KR20010034588A (no) |
| CN (1) | CN1292696A (no) |
| AR (1) | AR018147A1 (no) |
| AU (1) | AU748396C (no) |
| CA (1) | CA2323177A1 (no) |
| CO (1) | CO5080740A1 (no) |
| HU (1) | HUP0101043A3 (no) |
| IL (1) | IL138192A0 (no) |
| NO (1) | NO20004491L (no) |
| NZ (1) | NZ505807A (no) |
| PL (1) | PL342600A1 (no) |
| TR (1) | TR200002626T2 (no) |
| WO (1) | WO1999045924A1 (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2813651B1 (fr) | 2000-09-05 | 2004-06-11 | Valeo | Appareil d'accouplement hydrocinetique, notamment pour vehicule automobile |
| AU2002358270A1 (en) * | 2001-12-20 | 2003-07-09 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
| US20050079217A1 (en) * | 2002-07-25 | 2005-04-14 | Ganorkar Loksidh D. | Sustained-release tablet composition comprising a dopamine receptor agonist |
| AR040680A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Composicion de tabletas de liberacion sostenida |
| AR040682A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| EA200700388A1 (ru) * | 2004-08-13 | 2007-08-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ её изготовления и её применение |
| HRP20100682T4 (hr) * | 2004-08-13 | 2014-08-01 | Boehringer Ingelheim International Gmbh | Formulacija tablete produljenog oslobađanja koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu sol, postupak njezine priprave i uporaba |
| CA2641665A1 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Modified release formulation |
| US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
| US20080014257A1 (en) * | 2006-07-14 | 2008-01-17 | Par Pharmaceutical, Inc. | Oral dosage forms |
| WO2012027558A2 (en) * | 2010-08-25 | 2012-03-01 | The Trustees Of Columbia University In The City Of New York | OPTIMIZED miRNA CONSTRUCTS |
| ES2890492T3 (es) | 2015-07-20 | 2022-01-20 | Acadia Pharm Inc | Métodos para preparar N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida y su sal de tartrato y forma polimórfica C |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| EP3558311A1 (en) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
| EP3615028A1 (en) | 2017-04-28 | 2020-03-04 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| EP3675827A1 (en) | 2017-08-30 | 2020-07-08 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
| US11648242B2 (en) * | 2019-12-12 | 2023-05-16 | Aurobindo Pharma Ltd | Pharmaceutical composition comprising pimavanserin, process of preparation and use thereof |
| WO2026018155A1 (en) | 2024-07-16 | 2026-01-22 | Syremis Therapeutics Ltd. | Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists |
| WO2026018154A1 (en) | 2024-07-16 | 2026-01-22 | Syremis Therapeutics Ltd. | Combinations of sabcomeline with non-cns penetrant muscarinic antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU207444B (en) | 1990-07-12 | 1993-04-28 | Biorex Kutato Fejlesztoe Kft | Method for producing therapeutical preparation suitable for treating alzheimer-disease |
| US5433951A (en) * | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
| GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| AR004178A1 (es) * | 1995-07-29 | 1998-11-04 | Smithkline Beecham Plc | Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. |
| GB9619074D0 (en) * | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
-
1999
- 1999-03-05 IL IL13819299A patent/IL138192A0/xx unknown
- 1999-03-05 US US09/623,213 patent/US6451343B1/en not_active Expired - Fee Related
- 1999-03-05 CN CN998038202A patent/CN1292696A/zh active Pending
- 1999-03-05 TR TR2000/02626T patent/TR200002626T2/xx unknown
- 1999-03-05 CA CA002323177A patent/CA2323177A1/en not_active Abandoned
- 1999-03-05 EP EP99911765A patent/EP1061918A1/en not_active Withdrawn
- 1999-03-05 KR KR1020007010054A patent/KR20010034588A/ko not_active Withdrawn
- 1999-03-05 NZ NZ505807A patent/NZ505807A/xx unknown
- 1999-03-05 AU AU30332/99A patent/AU748396C/en not_active Ceased
- 1999-03-05 HU HU0101043A patent/HUP0101043A3/hu unknown
- 1999-03-05 PL PL99342600A patent/PL342600A1/xx unknown
- 1999-03-05 JP JP2000535339A patent/JP2002506031A/ja not_active Withdrawn
- 1999-03-05 WO PCT/EP1999/001557 patent/WO1999045924A1/en not_active Ceased
- 1999-03-09 AR ARP990100991A patent/AR018147A1/es unknown
- 1999-03-11 CO CO99015121A patent/CO5080740A1/es unknown
-
2000
- 2000-09-08 NO NO20004491A patent/NO20004491L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ505807A (en) | 2003-01-31 |
| EP1061918A1 (en) | 2000-12-27 |
| HUP0101043A3 (en) | 2002-02-28 |
| IL138192A0 (en) | 2001-11-25 |
| HUP0101043A2 (hu) | 2001-12-28 |
| KR20010034588A (ko) | 2001-04-25 |
| WO1999045924A1 (en) | 1999-09-16 |
| CA2323177A1 (en) | 1999-09-16 |
| CN1292696A (zh) | 2001-04-25 |
| TR200002626T2 (tr) | 2001-03-21 |
| AU748396B2 (en) | 2002-06-06 |
| JP2002506031A (ja) | 2002-02-26 |
| AU748396C (en) | 2003-01-23 |
| CO5080740A1 (es) | 2001-09-25 |
| AR018147A1 (es) | 2001-10-31 |
| PL342600A1 (en) | 2001-06-18 |
| US6451343B1 (en) | 2002-09-17 |
| AU3033299A (en) | 1999-09-27 |
| NO20004491L (no) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69941559D1 (de) | Enzymgemisch | |
| NO951704L (no) | Vann-avstötende blanding | |
| DK0900021T3 (da) | Fungicid blanding | |
| NO20002515D0 (no) | Mineralullblanding | |
| NO20001014D0 (no) | Dermatologisk blanding | |
| NO994003L (no) | Farmasoytisk blanding | |
| NO20000028L (no) | Mineralull-blanding | |
| ID23234A (id) | Turunan-turunan benzosulfona | |
| NO985864D0 (no) | Antiviral blanding | |
| NO20004491D0 (no) | Blanding | |
| DE59906237D1 (de) | Pigmentmischung | |
| ID23287A (id) | Trisiklik tersubstitusi | |
| NO20000030L (no) | Mineralullblanding | |
| DE69808366D1 (de) | Dimmer | |
| ID23219A (id) | Trisiklik tersubstitusi | |
| DK0986304T3 (da) | Fungicid blanding | |
| NO20020710D0 (no) | Varmelagrende blanding | |
| DK1139758T3 (da) | Fungicid blanding | |
| NO20000107D0 (no) | Ny blanding | |
| FI974212A7 (fi) | Eristin | |
| DE69923371D1 (de) | Koaxialkabel | |
| DE59911610D1 (de) | Substituierte benzoylcyclohexandione | |
| NO20003639D0 (no) | Oral oljeabsorberende blanding | |
| NO20003834D0 (no) | Blanding | |
| DE59810662D1 (de) | Koaxialverbinder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |